Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma

Bassem I. Razzouk, Shamala Srinivas, Clare E. Sample, Vivekanand Singh, John W. Sixbey

Research output: Contribution to journalArticlepeer-review

96 Scopus citations


Epstein-Barr virus (EBV) antigens in tumor tissue define associations of virus with human malignancies and provide clues as to mechanisms of viral oncogenesis. In Burkitt's lymphoma, EBV markers are absent from 85% of sporadic cases and 4% of endemic (African) cases, raising questions as to the exact role of EBV in the disease. Standard screening criteria may be insufficient to determine the EBV status of all tumors. One of 9 tumors from American patients expressed EBV nuclear antigen 1 (EBNA1) and contained standard episomal EBV DNA, making this series consistent with the 15% EBV association traditionally ascribed to sporadic Burkitt's lymphoma. Surprisingly, 3 tumors without detectable EBNA1 contained partial EBV genomes. Identification of defective, integrated viral DNA in some tumors indicates greater involvement of virus in sporadic Burkitt's lymphoma than previously documented and suggests a process of viral DNA rearrangement and loss during malignant progression most consistent with an initiating role for EBV in tumorigenesis.

Original languageEnglish (US)
Pages (from-to)529-535
Number of pages7
JournalJournal of Infectious Diseases
Issue number3
StatePublished - 1996

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Infectious Diseases


Dive into the research topics of 'Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma'. Together they form a unique fingerprint.

Cite this